$1.06
-0.03 (-2.75%)
Market Cap
$29.5M
Shares Outstanding
27,074,586
Institutional Holders
30
Total Inst. Value
$809K
% of Float Held
1.8%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | Murchinson Ltd. | $276K | 136,076 |
| 2 | UBS Group AG | $207K | 101,778 |
| 3 | GOLDMAN SACHS GROUP INC | $50K | 24,794 |
| 4 | BlackRock, Inc. | $47K | 23,241 |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $44K | 22,062 |
| 6 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $43K | 21 |
| 7 | Beacon Pointe Advisors, LLC | $38K | 18,845 |
| 8 | VANGUARD GROUP INC | $38K | 18,824 |
| 9 | WELLS FARGO & COMPANY/MN | $25K | 12,293 |
| 10 | Virtu Financial LLC | $22K | 10,666 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold BTAI?
As of Q1 2025, 30 institutional investors report holding BTAI (BioXcel Therapeutics, Inc.) in their 13F filings.
What percentage of BioXcel Therapeutics, Inc. is owned by institutions?
Institutional investors hold approximately 1.8% of BioXcel Therapeutics, Inc.'s float as reported in SEC 13F filings.
Which hedge fund owns the most BTAI?
The largest institutional holder of BTAI is Murchinson Ltd. with $276K in shares.
Are institutions buying or selling BTAI?
This quarter, 30 institutions opened new positions in BTAI and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.